Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial cell biomolecules is a generic term encompassing a diverse array of molecules found within or on the surface of epithelial cells, which constitute the lining of various organs and structures in the body (StatPearls: Epithelium, 2023). This category includes structural proteins like cytokeratins, adhesion molecules such as E-cadherin (CDH1) and EpCAM, and various receptors involved in cell signaling (NCBI Gene: CDH1, 2024; NCBI Gene: EPCAM, 2024). Because this term describes a broad class of biological components rather than a single, specific protein or receptor, it is not considered a valid therapeutic target for drug development. While specific molecules within this group are frequently targeted in the treatment of carcinomas and inflammatory conditions, the collective term lacks the specificity required for pharmacological intervention. Consequently, drug discovery efforts focus on individual, well-characterized members of this group rather than the category as a whole.
Not applicable as this is a broad category of molecules rather than a specific therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial cell biomolecules.